TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16601642

Group type: EXPERIMENTAL
Intervention: Usual treatment plus family psychoeducation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 41
Study: 12749524

Group type: EXPERIMENTAL
Intervention: Video-based home telecare
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telephone calls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In-person visits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 11191690

Group type: EXPERIMENTAL
Intervention: Fluvoxamine with behavior therapy (20 sessions)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fluvoxamine alone
Number of subjects: 10
Study: 8623947

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 186

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 186
Study: 1449045

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (hGH) 0.1 IU.kg‐1 body weight.d‐1
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: recombinant human growth hormone (hGH)
Number of subjects: 16
Study: 3904700

Group type: EXPERIMENTAL
Intervention: Alternative healing agents
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 18
Study: 30315763

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 50
Study: 29474289

Group type: EXPERIMENTAL
Intervention: Group A: Q‐tip touch test, speculum examination, then bimanual examination
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Group B: Q‐tip touch test, bimanual examination, then speculum examination
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (not explicitly defined in the abstract)
Number of subjects: 200
Study: 27544458

Group type: EXPERIMENTAL
Intervention: Power Through Choices (PTC) intervention
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1037
Study: 25371275

Group type: EXPERIMENTAL
Intervention: NSAID patch (ketoprofen)
Number of subjects: 99

Group type: COMPARATOR
Intervention: NSAID patch + TENS
Number of subjects: 99

Group type: COMPARATOR
Intervention: NSAID patch + heating pad
Number of subjects: 99

Group type: COMPARATOR
Intervention: NSAID patch + topical capsaicin
Number of subjects: 99
Study: 22260861

Group type: EXPERIMENTAL
Intervention: Amino acid mixture beverage (CHO/AA) consisting of 0.088 g cystine 2HCl, 0.043 g methionine, 0.086 g valine, 12.094 g isoleucine, 0.084 g leucine, and 100 g dextrose
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control beverage (CHO) consisting of 100 g dextrose only
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Amino acid mixture beverage (CHO/AA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control beverage (CHO)
Number of subjects: 22
Study: 20230319

Group type: EXPERIMENTAL
Intervention: 10 mg hyperbaric bupivacaine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 10 mg plain bupivacaine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 15 mg hyperbaric ropivacaine with fentanyl 20 μg
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 15 mg plain ropivacaine with fentanyl 20 μg
Number of subjects: 103
Study: 17053207

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate (50/500 micro g) twice daily
Number of subjects: 994

Group type: COMPARATOR
Intervention: Salmeterol (50 micro g) twice daily
Number of subjects: 994
Study: 15597187

Group type: EXPERIMENTAL
Intervention: Route descriptions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Survey descriptions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition/priming task and bird-flight distance comparison task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Symbolic distance effects
Number of subjects: 0
Study: 12237186

Group type: EXPERIMENTAL
Intervention: Needle acupuncture at distant points
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) of local myofascial trigger points
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham laser acupuncture (Sham)
Number of subjects: 36
Study: 8530854

Group type: EXPERIMENTAL
Intervention: MIBG scintigraphy
Number of subjects: 25

Group type: COMPARATOR
Intervention: TI scintigraphy
Number of subjects: 25
Study: 1496838

Group type: EXPERIMENTAL
Intervention: CO2-bathing series with light-motion therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no cure)
Number of subjects: 12
Study: 6648053

Group type: EXPERIMENTAL
Intervention: Combined regimen (2-mg tablet of salbutamol + 10 puffs of salbutamol inhalation)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol inhalation (100 micrograms per puff)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol tablet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (tablet and inhalation)
Number of subjects: 10
Study: 30362989

Group type: EXPERIMENTAL
Intervention: Pediatric Index of Mortality 3
Number of subjects: 1428

Group type: EXPERIMENTAL
Intervention: Pediatric Risk of Mortality III
Number of subjects: 1428
Study: 29758508

Group type: EXPERIMENTAL
Intervention: Kinesio™ Tape (KT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: RockTape™ (RT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No tape (NT)
Number of subjects: 12
Study: 25222428

Group type: EXPERIMENTAL
Intervention: CPAP and standard therapy
Number of subjects: 20
Study: 24952044

Group type: EXPERIMENTAL
Intervention: Intra-articular morphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intra-articular lidocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intra-articular morphine and lidocaine
Number of subjects: 0
Study: 21909946

Group type: EXPERIMENTAL
Intervention: Visual feedback (visualization of charts showing the progression of disease activity parameters) added to DMARDs therapy
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard management protocols (Control group)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Visual feedback (visualization of charts showing the progression of disease activity parameters)
Number of subjects: 111
Study: 21228500

Group type: EXPERIMENTAL
Intervention: Glycogen-loading regimen (3-day high-fat diet followed by 3-day high-carbohydrate diet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-carbohydrate diet (6-day duration)
Number of subjects: 0
Study: 18453320

Group type: EXPERIMENTAL
Intervention: Oat cereal (5.7 g/day beta-glucan)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Wheat cereal (control)
Number of subjects: 27
Study: 16635963

Group type: EXPERIMENTAL
Intervention: Urtica dioica
Number of subjects: 620

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 620
Study: 12010697

Group type: EXPERIMENTAL
Intervention: Use of a personal‐office‐visit diary
Number of subjects: 1038

Group type: COMPARATOR
Intervention: Control group (no diary)
Number of subjects: 1038
Study: 10529510

Group type: EXPERIMENTAL
Intervention: H. pylori positive gastritis
Number of subjects: 45

Group type: COMPARATOR
Intervention: H. pylori negative gastritis
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 45

Group type: COMPARATOR
Intervention: H. pylori negative chronic gastritis
Number of subjects: 45
Study: 8530122

Group type: EXPERIMENTAL
Intervention: Nurse-expressed empathy measures (Behavioral Test of Interpersonal Skills and Staff-Patient Interaction Response Scale)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Nurse-expressed empathy measures
Number of subjects: 140
Study: 2338469

Group type: EXPERIMENTAL
Intervention: Polocaine (mepivacaine hydrochloride)
Number of subjects: 40
Study: 7297020

Group type: EXPERIMENTAL
Intervention: 5 mg carteolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.5 mg carteolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 15 mg carteolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 60 mg carteolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31270291

Group type: EXPERIMENTAL
Intervention: Insulin degludec U100 (IDeg)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Insulin glargine U100 (IGla)
Number of subjects: 74
Study: 27634976

Group type: EXPERIMENTAL
Intervention: 100 mg daily aspirin
Number of subjects: 559

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 559
Study: 28039289

Group type: EXPERIMENTAL
Intervention: Medical mask (n=123)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Mask group (household members of index cases who used a mask)
Number of subjects: 245

Group type: COMPARATOR
Intervention: No-mask group (household members of index cases who did not use a mask)
Number of subjects: 245
Study: 24954805

Group type: EXPERIMENTAL
Intervention: Sequential treatment (paclitaxel then UFT)
Number of subjects: 1495

Group type: EXPERIMENTAL
Intervention: Sequential treatment (paclitaxel then S-1)
Number of subjects: 1495

Group type: COMPARATOR
Intervention: UFT monotherapy
Number of subjects: 1495

Group type: COMPARATOR
Intervention: S-1 monotherapy
Number of subjects: 1495
Study: 23098579

Group type: EXPERIMENTAL
Intervention: Hypofractionated tomotherapy (TT) - 15 × 2.8 Gy over 3 weeks, with a simultaneous integrated boost of 15 × 0.6 Gy over 3 weeks for BCS patients
Number of subjects: 121

Group type: COMPARATOR
Intervention: Conventional radiotherapy (CR) - 25 × 2 Gy over 5 weeks, with a sequential boost of 8 × 2 Gy over 2 weeks for BCS patients
Number of subjects: 121
Study: 19730900

Group type: EXPERIMENTAL
Intervention: Daptomycin 6 mg/kg/day
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard therapy (vancomycin 1 g every 12 h or antistaphylococcal penicillin 2 g every 4 h, both with gentamicin 1 mg/kg every 8 h for 4 days)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Non-diabetic patients
Number of subjects: 86
Study: 17514173

Group type: EXPERIMENTAL
Intervention: Minimally invasive lateral approach THA (study group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard lateral direct approach THA (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (study and control)
Number of subjects: 120
Study: 15368619

Group type: EXPERIMENTAL
Intervention: Trapeziectomy (group I)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ligament reconstruction/tendon interposition (group II)
Number of subjects: 56
Study: 11173126

Group type: EXPERIMENTAL
Intervention: Very large trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small trials based on biologic hypotheses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individualized strategies among patients with histologically similar tumors
Number of subjects: 0
Study: 9509352

Group type: EXPERIMENTAL
Intervention: PISA method
Number of subjects: 33

Group type: COMPARATOR
Intervention: Jet area method
Number of subjects: 33
Study: 7810090

Group type: EXPERIMENTAL
Intervention: Iso‐Mack retard + Moduretic (diuretic)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Iso‐Mack retard (nitrate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3133703

Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-alcoholic drink
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebos
Number of subjects: 12
Study: 30001923

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg once-daily
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 28634650

Group type: EXPERIMENTAL
Intervention: Z-360 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Z-360 120 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Z-360 240 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gemcitabine plus placebo (Gem group)
Number of subjects: 0
Study: 25413958

Group type: EXPERIMENTAL
Intervention: Enhanced ASV (PaceWave)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional ASV (AutoSetCS)
Number of subjects: 0
Study: 24282867

Group type: EXPERIMENTAL
Intervention: Waterpik Water Flosser plus a manual toothbrush (WF)
Number of subjects: 70

Group type: COMPARATOR
Intervention: waxed string floss plus a manual toothbrush (SF)
Number of subjects: 70
Study: 20438578

Group type: EXPERIMENTAL
Intervention: PEG‐IFN monotherapy at a dosage of 0.8 μg/kg per week (n = 12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PEG‐IFN (0.8 μg/kg per week) plus RIB (800‐1200 mg/d) (n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: PEG‐IFN monotherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: PEG‐IFN plus RIB
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 24
Study: 19502420

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (matched control subjects)
Number of subjects: 14
Study: 16814949

Group type: EXPERIMENTAL
Intervention: Radiotherapy +/− androgen deprivation
Number of subjects: 119
Study: 12869355

Group type: EXPERIMENTAL
Intervention: 1 mg 17beta‐estradiol orally + 100 mg progesterone daily
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: 50 microg 17beta‐estradiol transdermally per day + 100 mg progesterone daily
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo + 100 mg progesterone daily
Number of subjects: 196
Study: 10832774

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 9381513

Group type: EXPERIMENTAL
Intervention: Budesonide, 800 micrograms/d
Number of subjects: 16
Study: 8249953

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (10 micrograms) at 0, 1, 2, and 11 months of age with hepatitis B immune globulin (0.5 mL/kg) within 2 hours of birth (group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (10 micrograms) at 3, 4, 5, and 11 months of age with hepatitis B immune globulin (0.5 mL/kg) within 2 hours of birth and a second dose at 3 months (group B)
Number of subjects: 80
Study: 2876244

Group type: EXPERIMENTAL
Intervention: Community-based day centre (ACCEPT)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Standard hospital inpatient and outpatient services
Number of subjects: 151
Study: 30017630

Group type: EXPERIMENTAL
Intervention: Active working memory training (n=45)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control working memory training (n=36)
Number of subjects: 81
Study: 27362497

Group type: EXPERIMENTAL
Intervention: Day-camp intervention arm (six-week day-camp focusing on increased physical activity and healthy diet followed by a one-year family-based intervention)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Day-camp intervention arm
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard intervention arm (one weekly exercise session for six weeks)
Number of subjects: 115
Study: 24111649

Group type: EXPERIMENTAL
Intervention: Bilinaster drop (5 drop/kg every eight hours) and phototherapy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Glycerin suppository (half every twelve hours) and phototherapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (phototherapy only)
Number of subjects: 90
Study: 22227086

Group type: EXPERIMENTAL
Intervention: Protocol-based weaning (PBW) administered by nurses, n = 61
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual care (UC) managed by ICU physicians, n = 61
Number of subjects: 122
Study: 20391208

Group type: EXPERIMENTAL
Intervention: Intervention to boost perceived behavioural control (PBC) and create walking plans
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (waiting-list)
Number of subjects: 130
Study: 18347602

Group type: EXPERIMENTAL
Intervention: Genotyping for 492,900 single‐nucleotide polymorphisms (SNPs) using the Affymetrix 500K two‐chip genotyping platform plus a custom 164K fill‐in chip
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Logistic regression analyses for SNP association with schizophrenia
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Planned genomewide association study for response phenotypes
Number of subjects: 738
Study: 15817848

Group type: COMPARATOR
Intervention: Control group (established dietary intake)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Medium dairy group (calcium intake of approximately 1000-1100 mg/d)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: High dairy group (calcium intake of 1300-1400 mg/d)
Number of subjects: 155
Study: 12512990

Group type: EXPERIMENTAL
Intervention: Crest SpinBrush (experimental toothbrush)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Lion Dentor Systema (control toothbrush)
Number of subjects: 36
Study: 10333815

Group type: EXPERIMENTAL
Intervention: Assistive technology and environmental interventions (AT and EIs)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Usual care services (Control)
Number of subjects: 104
Study: 8944191

Group type: COMPARATOR
Intervention: Young control group (mean age 23.3 years)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Age-matched control group (mean age 70.3 years)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: ARM subjects (mean age 72.3 years)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Comparison between young control group and age-matched control group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Comparison between ARM subjects and age-matched controls
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Comparison between age-matched controls and ARM subjects
Number of subjects: 18
Study: 1958561

Group type: EXPERIMENTAL
Intervention: TE-300 mg/wk
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ND-300 mg/wk
Number of subjects: 30

Group type: COMPARATOR
Intervention: TE-100 mg/wk
Number of subjects: 30
Study: 6765140

Group type: COMPARATOR
Intervention: Acetylsalicylic acid and dipyridamol (1,050 mg + 150 mg/day) - group A
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1,200 mg/day) - group P
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 66
Study: 30704260

Group type: EXPERIMENTAL
Intervention: Early norepinephrine (n=155)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Standard treatment (n=155)
Number of subjects: 310
Study: 27922936

Group type: EXPERIMENTAL
Intervention: TX‐004HR 4μg
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: TX‐004HR 10μg
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: TX‐004HR 25μg
Number of subjects: 764

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: TX‐004HR (all doses)
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: TX‐004HR
Number of subjects: 764
Study: 25566954

Group type: EXPERIMENTAL
Intervention: Lower body positive pressure (LBPP) device at 60% body weight
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Lower body positive pressure (LBPP) device at 80% body weight
Number of subjects: 11

Group type: COMPARATOR
Intervention: 100% body weight (BW)
Number of subjects: 11
Study: 23444285

Group type: EXPERIMENTAL
Intervention: Modified-release prednisone tablets (5 mg) taken at bedtime
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional prednisone (5 mg)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Modified-release prednisone tablets taken with or after an evening meal
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Modified-release prednisone tablets taken under fasted conditions
Number of subjects: 33
Study: 21833690

Group type: EXPERIMENTAL
Intervention: Individual cognitive behavior therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated behavioral and family therapy (IBFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIV‐specific intervention
Number of subjects: 0
Study: 19217745

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 16930803

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 4 x 5 mg cetrorelix acetate
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 4 x 10 mg cetrorelix acetate
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: 2 x 10 mg cetrorelix acetate
Number of subjects: 109
Study: 14985989

Group type: EXPERIMENTAL
Intervention: Vibratory stimulation applied to the belly of the gastrocnemius muscles of both legs
Number of subjects: 70
Study: 12063916

Group type: EXPERIMENTAL
Intervention: Adjuvant chemoradiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 9823484

Group type: EXPERIMENTAL
Intervention: Greater interhemispheric connectivity observed in women as measured by the splenium of the corpus callosum.
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: New image analysis technique for investigating local variability in brain morphology.
Number of subjects: 114
Study: 7896672

Group type: EXPERIMENTAL
Intervention: 15-session cognitive group prevention intervention
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 150
Study: 2566287

Group type: EXPERIMENTAL
Intervention: Midazolam 7.5 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Temazepam 20 mg
Number of subjects: 60
Study: 782969

Group type: EXPERIMENTAL
Intervention: Recombinant WRL 105 live attenuated influenza virus vaccine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo nose drops
Number of subjects: 18

Group type: COMPARATOR
Intervention: Neither vaccine nor placebo
Number of subjects: 18
Study: 31573247

Group type: EXPERIMENTAL
Intervention: Memory error measurement for ^{43}Ca^{+} trapped-ion qubit with storage times t≲50  ms
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Randomized benchmarking at t=1  ms
Number of subjects: 1
Study: 28816343

Group type: EXPERIMENTAL
Intervention: Inactivity alerts from fitness trackers (every 15 or 20 minutes of inactivity)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reversal phase (removal of inactivity alerts)
Number of subjects: 10
Study: 25417069

Group type: EXPERIMENTAL
Intervention: Robotic sleeve gastrectomy
Number of subjects: 409

Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Both robotic and laparoscopic groups
Number of subjects: 409